These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26768621)

  • 1. Immune-Microbiota Interactions: Dysbiosis as a Global Health Issue.
    Logan AC; Jacka FN; Prescott SL
    Curr Allergy Asthma Rep; 2016 Feb; 16(2):13. PubMed ID: 26768621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self.
    Litvak Y; Bäumler AJ
    Immunity; 2019 Aug; 51(2):214-224. PubMed ID: 31433969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human microbiome in rheumatic autoimmune diseases: A comprehensive review.
    Coit P; Sawalha AH
    Clin Immunol; 2016 Sep; 170():70-9. PubMed ID: 27493014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the microbiota on the host immune system.
    Karczewski J; Poniedziałek B; Adamski Z; Rzymski P
    Autoimmunity; 2014 Dec; 47(8):494-504. PubMed ID: 25019177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of the microbiome in renal transplantation.
    Ahmad S; Bromberg JS
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):570-576. PubMed ID: 27517135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases.
    Prescott SL
    J Allergy Clin Immunol; 2013 Jan; 131(1):23-30. PubMed ID: 23265694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes.
    Proal AD; Lindseth IA; Marshall TG
    Discov Med; 2017 Jan; 23(124):51-60. PubMed ID: 28245427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.
    Lee KA; Lee WJ
    Dev Comp Immunol; 2014 Jan; 42(1):102-10. PubMed ID: 23685204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking the Microbiota, Chronic Disease, and the Immune System.
    Hand TW; Vujkovic-Cvijin I; Ridaura VK; Belkaid Y
    Trends Endocrinol Metab; 2016 Dec; 27(12):831-843. PubMed ID: 27623245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.
    Severance EG; Yolken RH
    Neurobiol Dis; 2020 Feb; 135():104331. PubMed ID: 30471416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota in T-cell homeostasis and inflammatory diseases.
    Lee N; Kim WU
    Exp Mol Med; 2017 May; 49(5):e340. PubMed ID: 28546563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial contributions to chronic inflammation and metabolic disease.
    Shanahan F; Sheehan D
    Curr Opin Clin Nutr Metab Care; 2016 Jul; 19(4):257-62. PubMed ID: 27097361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis.
    Jain N; Walker WA
    Nat Rev Gastroenterol Hepatol; 2015 Jan; 12(1):14-25. PubMed ID: 25201040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
    Doré J; Multon MC; Béhier JM;
    Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
    Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
    Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies.
    West CE; Renz H; Jenmalm MC; Kozyrskyj AL; Allen KJ; Vuillermin P; Prescott SL;
    J Allergy Clin Immunol; 2015 Jan; 135(1):3-13; quiz 14. PubMed ID: 25567038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbiome in early life: implications for health outcomes.
    Tamburini S; Shen N; Wu HC; Clemente JC
    Nat Med; 2016 Jul; 22(7):713-22. PubMed ID: 27387886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.